Clinical Trials
임상시험 트래커
국내사는 전체 임상 이력, 글로벌 메이저는 진행 중 파이프라인을 추적합니다. ClinicalTrials.gov API v2에서 6시간 주기로 수집합니다.
기업
21 results
- 1/2상모집 중단 (진행 중)· Moderate to Severe Ulcerative ColitisA Study to Evaluate the Activity, and Safety of Vixarelimab in Participants With Moderate to Severe Active Ulcerative Colitis
리드: 로슈
- 1/2상모집 중단 (진행 중)· AL AmyloidosisVenetoclax-Dexamethasone in Relapsed and/or Refractory t(11;14) Amyloidosis
협력: 로슈
- 1/2상모집 중단 (진행 중)· ALK Fusion-positive Solid or CNS TumorsA Study Evaluating the Safety, Pharmacokinetics, and Efficacy of Alectinib in Pediatric Participants With ALK Fusion-Positive Solid or CNS Tumors
리드: 로슈
- 1/2상모집 중단 (진행 중)· Metastatic Lung Non-Small Cell CarcinomaNecitumumab and Trastuzumab in Combination With Osimertinib for the Treatment of Refractory Epidermal Growth Factor Receptor (EGFR)-Mutated Stage IV Non-small Cell Lung Cancer
협력: 일라이 릴리, 로슈
- 1/2상모집 중단 (진행 중)· Chronic Myelomonocytic LeukemiaVenetoclax in Combination With ASTX727 for the Treatment of Treatment-Naive High-Risk Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia
협력: 로슈
- 1/2상모집 중단 (진행 중)· HER2-positive Breast CancerRadiation Therapy Followed by Intrathecal Trastuzumab/Pertuzumab in HER2+ Breast Leptomeningeal Disease
협력: 로슈
- 1/2상모집 중단 (진행 중)· Advanced Liver CancersA Study Evaluating the Efficacy and Safety of Multiple Immunotherapy-Based Treatment Combinations in Patients With Advanced Liver Cancers (Morpheus-Liver)
리드: 로슈
- 1/2상모집 중단 (진행 중)· Advanced Solid TumorsA Phase 1 Trial of ZN-A-1041 Enteric Capsules or Combination in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Advanced Solid Tumors
리드: 로슈
- 1/2상모집 중단 (진행 중)· Solid TumorsDose Escalation Study of a PD1-LAG3 Bispecific Antibody in Patients With Advanced and/or Metastatic Solid Tumors
리드: 로슈
- 1/2상모집 중단 (진행 중)· Lymphoma, Non-HodgkinA Study to Evaluate the Safety, Pharmacokinetics and Preliminary Anti-Tumor Activity of Englumafusp Alfa in Combination With Obinutuzumab and in Combination With Glofitamab Following a Pre-Treatment Dose of Obinutuzumab in Participants With Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma
리드: 로슈
- 1/2상모집 중단 (진행 중)· B-cell Non-Hodgkin LymphomaA Study to Evaluate the Safety and Efficacy of Mosunetuzumab (BTCT4465A) in Combination With Polatuzumab Vedotin in B-Cell Non-Hodgkin Lymphoma
리드: 로슈
- 1/2상모집 중단 (진행 중)· Non-Hodgkins LymphomaAn Open-Label Phase lB/II Study of Glofitamab and Atezolizumab or Polatuzumab Vedotin in Adult Patients With Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma
리드: 로슈
- 1/2상모집 중단 (진행 중)· Non-small Cell Lung CancerA Phase IB/II Study of Alectinib Combined With Cobimetinib in Advanced ALK-Rearranged (ALK+) NSCLC
협력: 로슈
- 1/2상모집 중단 (진행 중)· Bladder CancerA Phase II Study of Atezolizumab in Combination With Cisplatin + Gemcitabine Before Surgery to Remove the Bladder Cancer
협력: 로슈
- 1/2상모집 중단 (진행 중)· Age-Related Macular DegenerationSafety and Efficacy Study of OpRegen for Treatment of Advanced Dry-Form Age-Related Macular Degeneration
리드: 로슈
BioPulse가 제공하는 정보는 공개된 자료를 요약·정리한 것으로, 투자 조언이나 의료 조언이 아닙니다. 임상 데이터·규제 일정·공시 내용은 반드시 원문을 직접 확인하시기 바랍니다.